Radioactive Iodine: Recognizing the Need for Risk-Benefit Balance

J Clin Oncol. 2022 May 1;40(13):1396-1399. doi: 10.1200/JCO.22.00013. Epub 2022 Mar 17.

Authors

Andrew M McDonald^{1

2}, Brenessa Lindeman³, Deepti Bahl⁴

Affiliations

¹ Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL.
² Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL.
³ Department of Surgery, University of Alabama at Birmingham, Birmingham, AL.
⁴ Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, AL.

PMID: 35298297
DOI: 10.1200/JCO.22.00013

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Iodine Radioisotopes* / adverse effects
Risk Assessment
Thyroid Neoplasms* / radiotherapy
Thyroid Neoplasms* / surgery
Thyroidectomy

Substances

Iodine Radioisotopes